BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Rossi L, Zoratto F, Papa A, Iodice F, Minozzi M, Frati L, Tomao S. Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2010; 2(9): 348-359 [PMID: 21160806 DOI: 10.4251/wjgo.v2.i9.348]
URL: https://www.wjgnet.com/1948-5204/full/v2/i9/348.htm
(0) (0) (15051) (68)
Number Citing Articles
1
Anastasios J. Karayiannakis, Stylianos Kakolyris, Alexandra Giatromanolaki, Nikos Courcoutsakis, Helen Bolanaki, Leonidas Chelis, Efthimios Sivridis, Constantinos Simopoulos. Hepatoid Adenocarcinoma of the Gallbladder. Journal of Gastrointestinal Cancer 2012; 43(S1) doi: 10.1007/s12029-011-9326-5
2
Qun Wang, Yan-Jun Zhong, Jing-Ping Yuan, Li-Hua Shao, Jue Zhang, Li Tang, Shao-Ping Liu, Ya-Ping Hong, Raymond A Firestone, Yan Li. Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-192
3
Yichao Mo, Yaoyong Lu, Peng Wang, Simin Huang, Longguang He, Dasheng Li, Fuliang Li, Junwei Huang, Xiaoxia Lin, Xueru Li, Siyao Che, Qinshou Chen. Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma. Tumor Biology 2017; 39(2) doi: 10.1177/1010428317690999
4
坤 钱. Bevacizumab: Current Approach in the Treatment of Hepatocellular Carcinoma. Medical Diagnosis 2011; 1(01) doi: 10.12677/md.2011.11001
5
Wei-Cheng Liang, Jia-Lin Ren, Cheuk-Wa Wong, Sun-On Chan, Mary Miu-Yee Waye, Wei-Ming Fu, Jin-Fang Zhang. LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene 2018; 37(11) doi: 10.1038/s41388-017-0041-y
6
William Wei Sharr, See Ching Chan, Chung-Mau Lo. Section 3. Current Status of Downstaging of Hepatocellular Carcinoma Before Liver Transplantation. Transplantation 2014; 97(Supplement 8S) doi: 10.1097/01.tp.0000446267.19148.21
7
Jian Wang, Chang-Peng Zhu, Ping-Fang Hu, Hui Qian, Bei-Fang Ning, Qing Zhang, Fei Chen, Jiao Liu, Bin Shi, Xin Zhang, Wei-Fen Xie. FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition. Carcinogenesis 2014; 35(11) doi: 10.1093/carcin/bgu180
8
Anju Mullath, Murali Krishna. Hepatocellular carcinoma – time to take the ticket. World Journal of Gastrointestinal Surgery 2019; 11(6): 287-295 doi: 10.4240/wjgs.v11.i6.287
9
ZhongYu Jiang, Zhen Mao. Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinomaviaWnt/β-catenin signaling pathway. RSC Advances 2019; 9(61) doi: 10.1039/C9RA05933D
10
T.J. Vogl, F. Marquardt, W. Bechstein, J. Trojan, N.N.N. Naguib, T. Gruber-Rouh, M. Beeres, C. Lee. Interventionelle Therapie primärer Lebertumoren. Der Onkologe 2012; 18(7) doi: 10.1007/s00761-012-2237-7
11
Haowei Tai, Tejaswi Worlikar, Zhen Xu, J. Brian Fowlkes, Jiaqi Shi, Man Zhang. Quantification of Histotripsy Dosage Using Machine Learning-Enhanced Ultrasound Imaging Analysis: Correlation with Histological Outcomes. Academic Radiology 2026;  doi: 10.1016/j.acra.2026.05.010
12
Tianyi Xu, LiPing Wang, Peilin Jia, Xiaofeng Song, Zhongming Zhao. An Integrative Transcriptomic and Methylation Approach for Identifying Differentially Expressed Circular RNAs Associated with DNA Methylation Change. Biomedicines 2021; 9(6) doi: 10.3390/biomedicines9060657
13
Jianyong Lei, Wentao Wang, Lunan Yan. Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria. Journal of Gastrointestinal Surgery 2013; 17(8) doi: 10.1007/s11605-013-2229-y
14
Suling Chen, Fang Li, Haiyun Chai, Xin Tao, Haili Wang, Aifang Ji. miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma. Biochemical and Biophysical Research Communications 2015; 464(2) doi: 10.1016/j.bbrc.2015.06.168
15
FU-BIAO KANG, LING WANG, DONG LI, YIN-GE ZHANG, DIAN-XING SUN. Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Oncology Reports 2015; 33(1) doi: 10.3892/or.2014.3587
16
Hao Cai, Wentao Kong, Tie Zhou, Yudong Qiu. Radiofrequency Ablation Versus Reresection in Treating Recurrent Hepatocellular Carcinoma. Medicine 2014; 93(22) doi: 10.1097/MD.0000000000000122
17
Li-Li Zhang, Yan-Jun Guo, Chun-Na Zhao, Jian-Yun Gao. Effects and mechanism of miR–214 on hepatocellular carcinoma. Asian Pacific Journal of Tropical Medicine 2015; 8(5) doi: 10.1016/S1995-7645(14)60350-3
18
YuXiang Fang, Jing-Lun Xue, Qi Shen, Jinzhong Chen, Ling Tian. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012; 55(6) doi: 10.1002/hep.25576
19
Sihyung Wang, Youngmi Jung. Potential Role of Hedgehog Signaling in Radiation-induced Liver Fibrosis. Journal of Life Science 2013; 23(5) doi: 10.5352/JLS.2013.23.5.710
20
Xinfeng Fan, Haiyuan Du, Yaogui Sun, Junbing Jiang, Zhirui Wang, Wei Yin, Kuohai Fan, Hongquan Li. Suppression of the Wnt signaling pathway may contribute to the inhibition of proliferation of human hepatocellular carcinoma SMMC-7721 cells by esculetin. Oncology Letters 2017; 14(2) doi: 10.3892/ol.2017.6364
21
Juhyun Kim, Ranhui Won, Guyee Ban, Mi Ha Ju, Kyung Sook Cho, Sang Young Han, Jin-Sook Jeong, Seong-Wook Lee. Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation. Scientific Reports 2015; 5(1) doi: 10.1038/srep12315
22
Dan-dan Xiong, Yi-wu Dang, Peng Lin, Dong-yue Wen, Rong-quan He, Dian-zhong Luo, Zhen-bo Feng, Gang Chen. A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1593-5
23
Meng Gao, Hong Xu, Xu Bao, Chenghong Zhang, Xin Guan, Hongyan Liu, Li Lv, Sa Deng, Dongyan Gao, Changyuan Wang, Yan Tian. Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer. Life Sciences 2016; 165 doi: 10.1016/j.lfs.2016.09.008
24
Alissa Hendricks-Wenger, Sofie Saunier, Alexander Simon, Douglas Grider, David Luyimbazi, Irving C. Allen, Eli Vlaisavljevich. Histotripsy for the Treatment of Cholangiocarcinoma in a Patient-Derived Xenograft Mouse Model. Ultrasound in Medicine & Biology 2022; 48(2) doi: 10.1016/j.ultrasmedbio.2021.10.002
25
Minhee Kim, Su-Bin Kim, Jaehi Kim, Keun-Sik Kim, Dong-Eun Kim. Co-delivery of curcumin and PTTG1 siRNA by galactose receptor-targeted liposomes for enhanced anti-tumor effects in hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2023; 86 doi: 10.1016/j.jddst.2023.104692
26
Alireza Mafi, Hamidreza Rismanchi, Mohaddese Malek Mohammadi, Neda Hedayati, Seyedeh Sara Ghorbanhosseini, Seyed Ali Hosseini, Yasaman Gholinezhad, Rohollah Mousavi Dehmordi, Behrooz Ghezelbash, Fatemeh Zarepour, Seyed Pouya Taghavi, Zatollah Asemi, Mina Alimohammadi, Hamed Mirzaei. A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1224138
27
Ka Wing Ma, Kenneth Siu Ho Chok, Wong Hoi She, Albert Chi Yan Chan, Tan To Cheung, Wing Chiu Dai, James Yan Yue Fung, Chung Mau Lo. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Liver Transplantation 2018; 24(8) doi: 10.1002/lt.25033
28
Alissa Hendricks-Wenger, Peter Weber, Alex Simon, Sofie Saunier, Sheryl Coutermarsh-Ott, Douglas Grider, Joan Vidal-Jove, Irving Coy Allen, David Luyimbazi, Eli Vlaisavljevich. Histotripsy for the Treatment of Cholangiocarcinoma Liver Tumors: In Vivo Feasibility and Ex Vivo Dosimetry Study. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 2021; 68(9) doi: 10.1109/TUFFC.2021.3073563
29
Laura Contreras, Alfonso Rodríguez-Gil, Jordi Muntané, Jesús de la Cruz. Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells. Cancers 2022; 14(5) doi: 10.3390/cancers14051204
30
NAZIM SERDAR TURHAL, BERNA SAVAŞ, ÖZNUR ÇOŞKUN, EMINE BAŞ, BÜLENT KARABULUT, DENIZ NART, TANER KORKMAZ, DILEK YAVUZER, GÖKHAN DEMIR, GÜLEN DOĞUSOY, MEHMET ARTAÇ. Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study. Molecular and Clinical Oncology 2015; 3(6) doi: 10.3892/mco.2015.633
31
A Thelen, C Benckert, H-M Tautenhahn, H-M Hau, M Bartels, J Linnemann, J Bertolini, M Moche, C Wittekind, S Jonas. Liver resection for hepatocellular carcinoma in patients without cirrhosis. Journal of British Surgery 2013; 100(1) doi: 10.1002/bjs.8962
32
Vickie C. Kong, Michael Velec. Stereotactic Body Radiation Therapy for Liver Cancer: A Review of the Technology. Journal of Medical Imaging and Radiation Sciences 2015; 46(3) doi: 10.1016/j.jmir.2015.06.005
33
Y-J Liao, H-Y Bai, Z-H Li, J Zou, J-W Chen, F Zheng, J-X Zhang, S-J Mai, M-S Zeng, H-D Sun, J-X Pu, D Xie. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells. Cell Death & Disease 2014; 5(3) doi: 10.1038/cddis.2014.66
34
Wei-Cheng Liang, Cheuk-Wa Wong, Pu-Ping Liang, Mai Shi, Ye Cao, Shi-Tao Rao, Stephen Kwok-Wing Tsui, Mary Miu-Yee Waye, Qi Zhang, Wei-Ming Fu, Jin-Fang Zhang. Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biology 2019; 20(1) doi: 10.1186/s13059-019-1685-4
35
Rodrigo Martins Abreu, Camila Silva Ferreira, Paulo Dominguez Nasser, Luciana Oba Onishi Kikuchi, Flair José Carrilho, Suzane Kioko Ono. Hepatocellular Carcinoma: The Final Moments of Life. Journal of Cancer Therapy 2013; 4(02) doi: 10.4236/jct.2013.42A045
36
Weiwen Chen, Yurong Qiu. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma. Cell Biochemistry and Biophysics 2015; 72(2) doi: 10.1007/s12013-014-0456-9
37
Erkan Kahraman, Erdem Göker. Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways. Molecular Biology Reports 2022; 49(6) doi: 10.1007/s11033-022-07273-9
38
T.J. Vogl, B. Panahi, S. Fischer, N. Naguib, N.-E.A. Nour-Eldin, T. Gruber, J. Trojan, W. Bechstein, S. Zangos, K. Eichler. Interventionelle Therapie von Lungen- und Lebermetastasen. Der Onkologe 2014; 20(8) doi: 10.1007/s00761-014-2669-3
39
Wing Chiu Dai, Tan To Cheung. Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence. Expert Review of Anticancer Therapy 2016; 16(10) doi: 10.1080/14737140.2016.1226136
40
Thomas Yau, Hilda Wong, Pierre Chan, T. J. Yao, R. Pang, T. T. Cheung, S. T. Fan, Ronnie T. Poon. Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease. Investigational New Drugs 2012; 30(6) doi: 10.1007/s10637-012-9808-8
41
Dipanwita Sengupta, Kaustav Dutta Chowdhury, Avik Sarkar, Soumosish Paul, Gobinda Chandra Sadhukhan. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1) doi: 10.1016/j.bbagen.2013.08.020
42
Tejaswi Worlikar, Eli Vlaisavljevich, Tyler Gerhardson, Joan Greve, Shanshan Wan, Sibu Kuruvilla, Jonathan Lundt, Kimberly Ives, Timothy Hall, Theodore H. Welling, Fred Lee, Zhen Xu. Histotripsy for Non-Invasive Ablation of Hepatocellular Carcinoma (HCC) Tumor in a Subcutaneous Xenograft Murine Model. 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2018;  doi: 10.1109/EMBC.2018.8513650
43
John Chun-Hao Chen, Hui-Yen Chuang, Fei-Ting Hsu, Yi-Chen Chen, Yi-Chun Chien, Jeng-Jong Hwang. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget 2016; 7(51) doi: 10.18632/oncotarget.13398
44
Jian‐Bo Xu, Fu‐Zhen Qi, Gang Xu, Guo‐Feng Chen, Ming‐De Huang, Jian‐Huai Zhang. Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus‐related hepatocellular carcinoma: A meta‐analysis. Hepatology Research 2014; 44(2) doi: 10.1111/hepr.12109
45
A. Bauschke, A. Altendorf-Hofmann, M. Freesmeyer, T. Winkens, C. Malessa, J.-H. Schierz, U. Teichgraeber, U. Settmacher. Selektive interne Radioembolisation beim nichtresektablen hepatozellulären Karzinom. Der Chirurg 2016; 87(11) doi: 10.1007/s00104-016-0259-1
46
Shital S. Panchal, Somsuvra B. Ghatak, Abhishek B. Jha, Raoul Onattu. Reduction of liver tumerogenic effect of N-nitrosodiethylamine by treatment with ɣ-oryzanol in Balb/C mice. Environmental Toxicology and Pharmacology 2017; 56 doi: 10.1016/j.etap.2017.08.006
47
YUQING CHEN, AIMIN HUANG, MEIQIN GAO, YONGQIN YAN, WENMIN ZHANG. Potential therapeutic value of dendritic cells loaded with NY-ESO-1 protein for the immunotherapy of advanced hepatocellular carcinoma. International Journal of Molecular Medicine 2013; 32(6) doi: 10.3892/ijmm.2013.1510
48
Chengshuo Zhang, Baomin Chen, Ao Jiao, Feng Li, Ning Sun, Guoqing Zhang, Jialin Zhang. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5016-z
49
Nestor Prieto-Domínguez, Raquel Ordóñez, Anna Fernández, Andres García-Palomo, Jordi Muntané, Javier González-Gallego, José L. Mauriz. Modulation of Autophagy by Sorafenib: Effects on Treatment Response. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00151
50
RUI WU, LIANG DUAN, LIWEI YE, HAIYANG WANG, XIA YANG, YUNYUAN ZHANG, XIAN CHEN, YAN ZHANG, YAGUANG WENG, JINGYONG LUO, MIN TANG, QIONG SHI, TONGCHUAN HE, LAN ZHOU. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway. International Journal of Oncology 2013; 42(3) doi: 10.3892/ijo.2013.1796
51
Lisha Chen, Hongbing Yao, Kai Wang, Xiangfeng Liu. Long Non‐Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR‐143‐3p and Promotes Hepatocellular Carcinoma Progression. Journal of Cellular Biochemistry 2017; 118(12) doi: 10.1002/jcb.26158
52
Erik S. Knudsen, Purva Gopal, Amit G. Singal. The Changing Landscape of Hepatocellular Carcinoma. The American Journal of Pathology 2014; 184(3) doi: 10.1016/j.ajpath.2013.10.028
53
Linlin Lu, Juan Zhou, Jian Shi, Xiao-juan Peng, Xiao-xiao Qi, Ying Wang, Fang-yuan Li, Fu-Yuan Zhou, Liang Liu, Zhong-Qiu Liu, Qinghua Sun. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients. PLOS ONE 2015; 10(5) doi: 10.1371/journal.pone.0127524
54
K.W. Ma, A.C.Y. Chan, B.W.H. She, K.S.H. Chok, T.T. Cheung, J.W.C. Dai, J.Y.Y. Fung, C.M. Lo. Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation. Transplantation Proceedings 2018; 50(4) doi: 10.1016/j.transproceed.2018.01.025
55
Breno Boueri Affonso, Francisco Leonardo Galastri, Joaquim Mauricio da Motta Leal Filho, Felipe Nasser, Priscila Mina Falsarella, Rafael Noronha Cavalcante, Marcio Dias de Almeida, Guilherme Eduardo Gonçalves Felga, Leonardo Guedes Moreira Valle, Nelson Wolosker. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging. World Journal of Gastroenterology 2019; 25(37): 5687-5701 doi: 10.3748/wjg.v25.i37.5687
56
Yaqin Lu, Zhe Li, Chen Lin, Jian Zhang, Zhisen Shen. Translation role of circRNAs in cancers. Journal of Clinical Laboratory Analysis 2021; 35(7) doi: 10.1002/jcla.23866
57
Anupam Bishayee, Roslin J. Thoppil, Animesh Mandal, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Erzsébet Háznagy‐Radnai, Judit Hohmann, Deepak Bhatia. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine‐initiated hepatocarcinogenesis by suppression of the inflammatory response. Molecular Carcinogenesis 2013; 52(4) doi: 10.1002/mc.21860
58
L. V. Klotz, M. E. Eichhorn, B. Schwarz, H. Seeliger, M. K. Angele, K.-W. Jauch, Christiane J. Bruns. Targeting the vasculature of visceral tumors: novel insights and treatment perspectives. Langenbeck's Archives of Surgery 2012; 397(4) doi: 10.1007/s00423-012-0946-4
59
A N Gordon-Weeks, A Snaith, T Petrinic, P J Friend, A Burls, M A Silva. Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. British Journal of Surgery 2011; 98(9) doi: 10.1002/bjs.7561
60
Won‐Chul Lim, Hyunhee Kim, Hyeonseok Ko. Delphinidin inhibits epidermal growth factor‐induced epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells. Journal of Cellular Biochemistry 2019; 120(6) doi: 10.1002/jcb.28271
61
Ping Fang, Jin-hua Hu, Zhi-gang Cheng, Zhe-feng Liu, Jin-liang Wang, Shun-chang Jiao, Xiaolin Zi. Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials. PLoS ONE 2012; 7(12) doi: 10.1371/journal.pone.0049717
62
Sara Carbajo-Pescador, Andrés García-Palomo, Javier Martín-Renedo, Maiara Piva, Javier González-Gallego, José L. Mauriz. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor. Journal of Pineal Research 2011; 51(4) doi: 10.1111/j.1600-079X.2011.00910.x
63
Monika Pazgan-Simon, Sylwia Serafinska, Justyna Janocha-Litwin, Krzysztof Simon, Jolanta Zuwala-Jagiello. Diagnostic Challenges in Primary Hepatocellular Carcinoma: Case Reports and Review of the Literature. Case Reports in Oncological Medicine 2015; 2015 doi: 10.1155/2015/878763
64
Xu Bao, Meng Gao, Hong Xu, Ke-Xin Liu, Cheng-Hong Zhang, Ni Jiang, Qiu-Chen Chu, Xin Guan, Yan Tian. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Drug Development and Industrial Pharmacy 2015; 41(7) doi: 10.3109/03639045.2014.938081
65
Ka Wing Ma, Tan To Cheung. When to Consider Liver Transplantation in Hepatocellular Carcinoma Patients?. Hepatic Oncology 2017; 4(1) doi: 10.2217/hep-2016-0010
66
Qian Lei, Lidan Zhang, Yong Xia, Tinghong Ye, Fangfang Yang, Yongxia Zhu, Xuejiao Song, Ningyu Wang, Ying Xu, Xiaowei Liu, Luoting Yu. A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosis. RSC Advances 2015; 5(52) doi: 10.1039/C5RA05387K
67
Mostafa M. Shakweer, Abdelshafy A. Awad Allah, Abdel-Aziz K. Aun. Common interventional techniques (single versus combined) in management of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(4) doi: 10.1016/j.ejrnm.2016.07.001
68
Tejaswi Worlikar, Mishal Mendiratta-Lala, Eli Vlaisavljevich, Ryan Hubbard, Jiaqi Shi, Timothy L. Hall, Clifford S. Cho, Fred T. Lee, Joan Greve, Zhen Xu. Effects of Histotripsy on Local Tumor Progression in an in vivo Orthotopic Rodent Liver Tumor Model . BME Frontiers 2020; 2020 doi: 10.34133/2020/9830304
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.